Hepatitis C News and Research

Latest Hepatitis C News and Research

Zoo data show low incidence of animal–human infection

Zoonotic transmission rates are low and the risk for animal–human infection is well managed, show zoo data spanning 19 years.

19 Dec 2012

Study highlights need for health services and social support for parolees

More than 40% of parolees and releases sent to the Bronx from New York State prisons have two or more major chronic conditions, a study to be released today at a public briefing at Health People: Community Preventive Health Institute in the Bronx shows.

19 Dec 2012

MiR-122 plays a critical role in the life cycle of hepatitis C virus

Hepatitis C virus has evolved to invade and hijack the basic machinery of the human liver cell to ensure its survival and spread. Researchers at the University of North have discovered how hepatitis C binds with and repurposes a basic component of cellular metabolism known as a microRNA to help protect and replicate the virus.

19 Dec 2012

Long-term antiviral HBV treatment advocated

Study results support the long-term use of tenofovir disoproxil fumarate for chronic hepatitis B virus, showing that it can suppress the virus and lead to regression of fibrosis and cirrhosis in patients after 5 years’ treatment.

17 Dec 2012

New report provides snapshot of Canada's cancer system

A comprehensive report released today by the Canadian Partnership Against Cancer provides a snapshot of how Canada's cancer system is performing in key areas from prevention through to patient experience and outcomes.

17 Dec 2012

Malaria vaccine trial: an interview with Professor Sir Brian Greenwood

Malaria is an infection caused by a parasite called plasmodium, which is transmitted from person to person by females of some species of mosquito. It is primarily a disease of tropical countries.

14 Dec 2012

Medivir commences cohort 2 simeprevir and sofosbuvir phase II combination trial in HCV GT1

Medivir AB, announced today the initiation of cohort 2 in the interferon-free phase II trial combining simeprevir with sofosbuvir (GS7977) based on a safety and efficacy planned interim analysis of cohort 1 including prior null responder HCV genotype 1 infected patients without advanced hepatic fibrosis.

13 Dec 2012

Patients with multiple sclerosis have low levels of Egr2/3 protein in T lymphocytes

Researchers from Queen Mary, University of London have discovered that two proteins which are believed to play a key role in controlling the body's immune response are found in lower levels in T lymphocytes from patients with multiple sclerosis (MS).

13 Dec 2012

Researchers discover a trigger by which the HCV enters liver cells

Researchers at the University of Southern California (USC) have discovered a trigger by which the Hepatitis C virus enters liver cells ─ shedding light on how this serious and potentially deadly virus can begin to damage the liver.

13 Dec 2012

Roundup: NH hospital at center of hepatitis outbreak details fixes; Report finds racial gap in Colo. dental coverage; Health cuts part of Conn. budget plan

Though Exeter Hospital has fixed problems discovered after a hepatitis C outbreak last spring, federal officials say the hospital initially failed to conduct an adequate investigation. The Centers for Medicare and Medicaid Services said last week it no longer plans to terminate the hospital's Medicare funding now that multiple issues raised by inspectors have been addressed.

11 Dec 2012

Risk factors revealed for anti-tuberculosis drug hepatotoxicity

The risk for hepatotoxicity among patients treated with anti-tuberculosis drugs is affected by gender, ethnicity, and the presence of genetic polymorphisms, say Argentinean researchers.

10 Dec 2012

Despite effective anti-viral drugs, majority of HCV patients remain untreated

Just 20 percent of people infected with the hepatitis C virus (HCV) begin the recommended treatment regimen and less than 5 percent go on to successfully overcome the virus, according to a new review in General Hospital Psychiatry.

10 Dec 2012

New public-private partnership will allow Brazil to produce patented ARV for national treatment program

For the first time, Brazil in 2013 will enter into a new type of public-private partnership that allows the nation to produce a generic version of the antiretroviral (ARV) drug atazanavir sulphate, which will be under patent through its producer Bristol-Myers Squibb until 2017, Inter Press Service reports.

8 Dec 2012

Baby boomers with liver cancer drive demand for liver transplantation

New research reveals that the greatest demand for liver transplantation due to hepatitis C (HCV)-related liver disease occurs among Americans born between 1941 and 1960. Findings in the December issue of Liver Transplantation, a journal published by Wiley on behalf of the American Association for the Study of Liver Diseases (AASLD), suggest that continuing increased demand for transplantation is driven by the development of liver cancer in baby boomers with HCV, but that the demand may decrease as patients born in this time period continue to grow older.

7 Dec 2012

Tenofovir DF safe and effective in treating adolescents with HBV

A recent clinical trial found that the adult antiviral drug, tenofovir disoproxil fumarate (tenofovir DF), is safe and effective in treating adolescents with hepatitis B virus (HBV). Trial results published in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases (AASLD), show that tenofovir DF suppressed HBV in 89% of pediatric participants.

6 Dec 2012

Task Force set to back CDC hepatitis C screening

Clinicians should consider screening for hepatitis C virus in all patients born between 1945 and 1965, the US Preventive Services Task Force says in draft guidance.

3 Dec 2012

Men should see a doctor and be proactive about their health, say UAB experts

Experts at the University of Alabama at Birmingham (UAB) say a man's tendency to wait until the onset of sickness to see his doctor is a major detriment to health because key screenings are missed.

1 Dec 2012

Loss of either T-bet or Eomes protein reduces immune system's ability to fight viral infection

When you get an acute infection, such as influenza, the body generally responds with a coordinated response of immune-cell proliferation and attack that rapidly clears the pathogen. Then, their mission done, the immune system stands down, leaving a population of sentinel memory cells to rapidly redeploy the immune system in the event of reinfection.

1 Dec 2012

Traveling med tech indicted on new charges related to hepatitis C outbreak

The technician was indicated Wednesday in New Hampshire on 14 new charges. The outbreak involved more than 30 patients in New Hampshire while people in a number of other states were exposed.

1 Dec 2012

Home Access Health urges individuals at risk for HIV infection to get tested

Home Access Health Corporation, America's leading provider of at-home HIV tests, today recognized World Aids Day Saturday by urging individuals at risk for HIV infection to get tested.

30 Nov 2012

Hepatitis C News and Research

Latest Hepatitis C News and Research

Zoo data show low incidence of animal–human infection

Study highlights need for health services and social support for parolees

MiR-122 plays a critical role in the life cycle of hepatitis C virus

Long-term antiviral HBV treatment advocated

New report provides snapshot of Canada's cancer system

Malaria vaccine trial: an interview with Professor Sir Brian Greenwood

Medivir commences cohort 2 simeprevir and sofosbuvir phase II combination trial in HCV GT1

Patients with multiple sclerosis have low levels of Egr2/3 protein in T lymphocytes

Researchers discover a trigger by which the HCV enters liver cells

Roundup: NH hospital at center of hepatitis outbreak details fixes; Report finds racial gap in Colo. dental coverage; Health cuts part of Conn. budget plan

Risk factors revealed for anti-tuberculosis drug hepatotoxicity

Despite effective anti-viral drugs, majority of HCV patients remain untreated

New public-private partnership will allow Brazil to produce patented ARV for national treatment program

Baby boomers with liver cancer drive demand for liver transplantation

Tenofovir DF safe and effective in treating adolescents with HBV

Task Force set to back CDC hepatitis C screening

Men should see a doctor and be proactive about their health, say UAB experts

Loss of either T-bet or Eomes protein reduces immune system's ability to fight viral infection

Traveling med tech indicted on new charges related to hepatitis C outbreak

Home Access Health urges individuals at risk for HIV infection to get tested

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Hepatitis C News and Research

Latest Hepatitis C News and Research

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Newsletters you may be interested in